These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16141975)

  • 41. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey.
    Wang YL; Wu D; Nguyen-Huynh MN; Zhou Y; Wang CX; Zhao XQ; Liao XL; Liu LP; Wang YJ;
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):775-81. PubMed ID: 20456429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trials on blood pressure-lowering and secondary stroke prevention.
    Chalmers J
    Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antithrombotic drugs in the prevention of ischemic stroke].
    Bousser MG
    J Mal Vasc; 2005 Dec; 30(5):267-79. PubMed ID: 16439939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safely Addressing Patients with Atrial Fibrillation to Early Anticoagulation after Acute Stroke.
    Canavero I; Cavallini A; Sacchi L; Quaglini S; Arnò N; Perrone P; DeLodovici ML; Marcheselli S; Micieli G
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):7-18. PubMed ID: 27614403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute management and secondary prevention of ischemic stroke].
    Mahagne MH
    Presse Med; 2007 Jan; 36(1 Pt 2):128-33. PubMed ID: 17296480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
    Arima H; Tzourio C; Butcher K; Anderson C; Bousser MG; Lees KR; Reid JL; Omae T; Woodward M; MacMahon S; Chalmers J;
    Stroke; 2006 Jun; 37(6):1497-502. PubMed ID: 16627794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New evidence for stroke prevention: scientific review.
    Straus SE; Majumdar SR; McAlister FA
    JAMA; 2002 Sep; 288(11):1388-95. PubMed ID: 12234233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?
    Farquhar D
    CMAJ; 2001 Feb; 164(3):396. PubMed ID: 11232150
    [No Abstract]   [Full Text] [Related]  

  • 53. Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.
    Deplanque D; Leys D; Parnetti L; Schmidt R; Ferro J; de Reuck J; Mas JL; Gallai V;
    Cerebrovasc Dis; 2006; 21(5-6):372-9. PubMed ID: 16490950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
    Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
    Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress in reducing the burden of stroke.
    Chalmers J; Chapman N
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.
    Kim BJ; Kang HG; Lee DH; Kang DW; Kim JS; Kwon SU
    Int J Stroke; 2015 Aug; 10(6):E68. PubMed ID: 26202718
    [No Abstract]   [Full Text] [Related]  

  • 57. [Benefit of a short atherosclerosis prevention program on post-stroke vascular risk reduction].
    Kazadi A; Sibon I; Lafitte M; Pucheu Y; Renou P; Rouanet F; Couffinhal T
    Rev Neurol (Paris); 2013 Apr; 169(4):314-20. PubMed ID: 23433881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of cardiovascular events in elderly people.
    Andrawes WF; Bussy C; Belmin J
    Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.